HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 15, Pages 3862
Publisher
MDPI AG
Online
2021-08-02
DOI
10.3390/cancers13153862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Sirtuins in Metabolic and Epigenetic Regulation of Stem Cells
- (2019) Yi Fang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
- (2019) Shilei Liu et al. CANCER SCIENCE
- The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered histone H3K9 marks in myeloid leukaemia cells
- (2019) Kathryn Clarke et al. Oncotarget
- The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
- (2018) Christian Mayr et al. HUMAN PATHOLOGY
- HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells
- (2018) Joon Wang et al. ONCOLOGY REPORTS
- Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome
- (2017) Eckhard Klieser et al. HUMAN PATHOLOGY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
- (2017) Yuyao Yin et al. Cell Death & Disease
- Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
- (2017) Mingming Zhang et al. Oncotarget
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Use of class I histone deacetylase inhibitor romidepsin in combination regimens
- (2016) Adam Petrich et al. LEUKEMIA & LYMPHOMA
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
- (2016) Takuya Sakamoto et al. PLoS One
- Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines
- (2015) MD. ALI ASGAR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
- (2015) Christian Mayr et al. Oncotarget
- The role of polycomb repressive complexes in biliary tract cancer
- (2014) Christian Mayr et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
- (2014) Victoria L. Luchenko et al. Molecular Oncology
- The interplay between microRNAs and histone deacetylases in neurological diseases
- (2014) Megan W. Bourassa et al. NEUROCHEMISTRY INTERNATIONAL
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
- (2013) J. W. Valle et al. ANNALS OF ONCOLOGY
- Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings
- (2013) Ruethairat Sriraksa et al. Asian Pacific Journal of Cancer Prevention
- Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells
- (2012) Linda Marek et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Overexpression of Histone Deacetylase 2 Predicts Unfavorable Prognosis in Human Gallbladder Carcinoma
- (2012) Xilin Du et al. PATHOLOGY & ONCOLOGY RESEARCH
- Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
- (2011) J Chang et al. BRITISH JOURNAL OF CANCER
- Romidepsin: a novel histone deacetylase inhibitor for cancer
- (2011) Erin M Bertino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of histone deacetylase expression in intrahepatic cholangiocarcinoma
- (2011) Yuji Morine et al. SURGERY
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Uptake and phototoxicity of meso-tetrahydroxyphenyl chlorine are highly variable in human biliary tract cancer cell lines and correlate with markers of differentiation and proliferation
- (2010) Tobias Kiesslich et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
- (2009) Junpei Yamaguchi et al. CANCER SCIENCE
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines
- (2008) Li-Ning Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search